Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
03/2010
03/10/2010CN100593540C Method for preparing 5-amido-1-(2,6-dichlorin-4-trifluoro methylbenzene)-3-cyano pyrazole
03/09/2010US7674911 Method for the production of hydrogen-bis (chelato) borates and alkali metal-bis (chelato) borates
03/09/2010US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
03/09/2010US7674828 Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditions
03/09/2010US7674825 Cardiovascular disorders; stimulant of guanylate cyclase
03/09/2010US7674813 Lowering beta amyloid; Alzheimer's disease; gamma secretase inhibitors; pyrazole, imidazole, pyrrole and 1,2,4-triazole sulfonamides; e.g. 5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide
03/09/2010US7674807 N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-methanesulfonyloxy-phthalamic acid; 3-fluoro-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid; effect against harmful insects without giving phytotoxicity on cultured plants
03/09/2010CA2403942C Benzoylpyrazoles and their use as herbicides
03/09/2010CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators
03/09/2010CA2306313C Dipeptide nitriles
03/04/2010WO2010023448A1 Novel potassium channel blockers
03/04/2010WO2010023446A1 Novel potassium channel blockers
03/04/2010WO2010023445A1 Novel potassium channel blocker
03/04/2010WO2010023307A1 Novel urea and thiourea derivatives
03/04/2010WO2009124950A3 4-methyl-4,5-dihydro-1h-pyrazole-3-carboxamide useful as a cannabinoid cb1 neutral antagonist
03/04/2010US20100056800 Method of synthesizing 1h-indazole compounds
03/04/2010US20100056786 Method for Producing Alkylanilides from Halobenzene Derivatives
03/04/2010US20100056758 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
03/04/2010US20100056596 Resistance-repellent retroviral protease inhibitors
03/04/2010US20100056595 Pyrazole Derivatives as P2X7 Modulators
03/04/2010US20100056573 2-alkyl-indazole compounds for the treatment of certain cns-related disorders
03/04/2010US20100056527 Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
03/04/2010US20100055116 Methods and Compositions for Targeting c-Rel
03/04/2010CA2735373A1 Novel urea and thiourea derivatives
03/03/2010EP2159216A1 Ih - Modulators
03/03/2010EP2158185A2 Method for producing difluoromethyl-substituted pyrazole compounds
03/03/2010EP2158184A2 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
03/03/2010CN101663279A inhibitors of mek
03/03/2010CN101659639A Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
03/02/2010US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide
03/02/2010US7671072 benzyl-carbamic acid cis-3-[5-(cyclohexanecarbonyl-amino)-1H-pyrazol-3-yl]-cyclobutyl ester; glycogen synthase kinase-3 (GSK-3) inhibitors; inter alia, Alzheimer's Disease, cancer, dementia, depression, diabetes, hair loss, schizophrenia, and stroke
03/02/2010US7671064 angiogenesis inhibitors; as antitumor agents; kinase inhibitors like vascular endothelial growth factor receptors antagonists
02/2010
02/25/2010WO2010021882A2 Cold menthol receptor antagonists
02/25/2010WO2010020548A1 Glyt1 receptor antagonists
02/25/2010WO2010020307A2 Indazole-5-carboxylic acid hydrazide derivatives
02/25/2010WO2009133179A3 Method for the production of halogen-substituted 2-(aminomethylidene)-3- oxobutyric acid esters
02/25/2010WO2009110985A3 Amide compounds, compositions and uses thereof
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
02/25/2010DE102008039083A1 Substituierte 5-Aminopyrazole und ihre Verwendung Substituted 5-aminopyrazoles and their use
02/25/2010DE102008039082A1 Azabicyclisch-substituierte 5-Aminopyrazole und ihre Verwendung Azabicyclisch-substituted 5-aminopyrazoles and their use
02/25/2010DE102008038222A1 Indazol-5-carbonsäurehydrazid-derivate Indazole-5-carboxylic acid derivatives
02/25/2010CA2734900A1 Polymorphic form of granisetron hydrochloride and methods of making the same
02/24/2010EP2155699A1 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
02/24/2010EP2155690A1 Indazolamide derivatives
02/24/2010EP2155689A2 Ccr2 receptor antagonists and uses thereof
02/24/2010EP2155688A2 Dinitropyrazole derivatives, their preparation, and energetic compositions comprising them.
02/24/2010EP2155687A1 Diacylglycerol acyltransferase inhibitors
02/24/2010EP2155686A1 Pyrazole carboxylic acid amides useful as microbiocides
02/24/2010EP2155685A1 Pyrazole derivatives as p2x7 modulators
02/24/2010EP2155675A1 Kinase inhibitors, compositions thereof, and methods of use therewith
02/24/2010EP1931335B1 Hexahydro cyclooctyl pyrazole cannabinoid modulators
02/24/2010EP1761499B1 1-methyl-3-trifluoromethyl-pyrazole-4-carboxylic acid (ortho-phenyl)-anilides and to use thereof as fungicide
02/24/2010CN101657427A 4-(3-aminobenzoyl)-1-methyl pyrazoles and their application as herbicides
02/24/2010CN101657426A 4-(3-aminobenzoyl)-1-ethyl pyrazoles and their application as herbicides
02/24/2010CN101657425A 4-(3-aminobenzoyl)-1.3-dimethyl pyrazoles and their application as herbicides
02/24/2010CN100591676C 2- and 2,5-substituted phenylketo-enols
02/23/2010US7666895 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
02/23/2010US7666888 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity
02/23/2010US7666882 1-(3-Chloro-2-pyridinyl)-N-[2,4-dichloro-6-[[(1-methylethyl)amino]carbonyl]phenyl]-3-(2-propynyloxy)-1H-pyrazole-5-carboxamide; controlling an invertebrate pest; less costly, less toxic, environmentally safer
02/23/2010US7666868 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
02/23/2010US7666867 Heteroindanes: a new class of potent cannabimimetic ligands
02/23/2010US7666866 Antithrombotic diamides
02/23/2010CA2442974C Use of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of cell proliferation diseases
02/23/2010CA2355214C Control of arthropods in animals with use of non-emetic 1-arylpyrazoles
02/18/2010WO2010019828A1 Glucagon receptor antagonists
02/18/2010WO2010018874A1 Amide compound
02/18/2010WO2010017902A1 Insecticidal 4-phenyl-1h-pyrazoles
02/18/2010US20100041899 Method for producing substituted pyrazolecarboxylic acid chlorides
02/18/2010US20100041727 Crystalline Modification of Fipronil
02/18/2010US20100041726 INHIBITORS OF Akt ACTIVITY
02/18/2010US20100041720 Novel compounds as cannabinoid receptor ligands
02/18/2010US20100041709 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
02/18/2010US20100041665 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
02/18/2010US20100041656 Novel amide derivatives and medicinal use thereof
02/18/2010US20100041552 Crystalline Modification of Fipronil
02/18/2010CA2733958A1 Insecticidal 4-phenyl-1h-pyrazoles
02/17/2010EP2152664A1 Dipeptide analogs as coagulation factor inhibitors
02/17/2010CN101652349A Cosmetic preparations designed to reduce unsightly cellulite
02/16/2010US7662961 5,5'-{Oxybis[ethane-2,1-diyl(methylimino)]}bis[1-(2,6-dichloro-4-trifluoromethylphenyl)-3-cyano-4-trifluoromethylsulfonylpyrazole]; pest control of insects, arachnids and helminths
02/16/2010US7662846 Selective spirocyclic glucocorticoid receptor modulators
02/16/2010US7662844 1-[6-(2-Dimethylamino-1-imidazol-1-yl-propyl)-naphthalen-2-yloxymethyl]-cyclopropanecarboxylic acid; enzyme inhibitor; for the treatment of various diseases that respond to treatment by retinoids and by naturally occurring retinoic acid
02/16/2010US7662836 Indazole having analgesic activity
02/16/2010US7662827 Pyrazole derivatives having tyrosine kinase inhibitory activity
02/16/2010US7662821 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
02/16/2010US7662804 Selective, tissue-specific TPO receptor agonists; thrombocytopenia resulting from radiation or chemotherapy; drug screening; [(N-substituted-2-oxo-1,2-dihydroindol-3-ylidene)hydrazino]-2-phenols; amyotrophic lateral sclerosis, multiple sclerosis, spinal cord injuries, muscular dystrophy
02/16/2010CA2478183C Substituted amides
02/16/2010CA2442882C Sulphones which modulate the action of gamma-secretase
02/16/2010CA2410399C 5-aminoalkylpyrazolo[4,3-d]pyrimidines
02/16/2010CA2408694C Process for the preparation of substituted pyrazole pesticidal compounds and novel intermediates thereof
02/16/2010CA2385081C Carboxylic acid compound and a medicament comprising it
02/11/2010WO2010017060A1 Urea derivatives as antibacterial agents
02/11/2010WO2010016230A1 Sulfoxyimino-substituted benzoyl derivative and herbicide
02/11/2010WO2010015657A2 New alkoxypyrazoles
02/11/2010WO2010015656A2 New alkoxypyrazoles
02/11/2010WO2010015613A1 Organic compounds
02/11/2010US20100035953 Pyrazole Phenyl Derivatives
02/11/2010US20100035948 Furanone compounds and lactam analogues thereof
02/11/2010US20100035936 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
02/11/2010US20100035926 Pyrazole derivatives as non-steroidal glucocorticoid receptor ligands
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 256